David Raben
Chief Medical Officer · 5 filings · Latest: Oct 1, 2026
Bicara Therapeutics Inc.
PLIANT THERAPEUTICS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BCAX | DAVID RABEN | — | Jul 8, 2026 | Proposed Sale | $28.56 | 50,000 | $1.4M | — | |
BCAX | DAVID RABEN | — | Jun 25, 2026 | Proposed Sale | $26.49 | 50,000 | $1.3M | — | |
BCAX | Raben David | — | May 26, 2026 | Proposed Sale | $21.82 | 5,500 | $120.0K | — | |
BCAX | David Raben | Chief Medical Officer | Apr 27, 2026 | Sale | $22.88 | 5,500 | $125.8K | 55,286 | |
BCAX | David Raben | Chief Medical Officer | Apr 27, 2026 | Option Exercise | $3.79 | 5,500 | $20.8K | 60,786 | |
BCAX | Raben David | — | Apr 27, 2026 | Proposed Sale | $22.88 | 5,500 | $125.8K | — | |
BCAX | David Raben | Chief Medical Officer | Mar 25, 2026 | Sale | $18.95 | 5,500 | $104.2K | 55,286 | |
BCAX | David Raben | Chief Medical Officer | Mar 25, 2026 | Option Exercise | $3.79 | 5,500 | $20.8K | 60,786 | |
BCAX | Raben David | — | Mar 25, 2026 | Proposed Sale | $18.95 | 5,500 | $104.2K | — | |
BCAX | David Raben | Chief Medical Officer | Mar 4, 2026 | Sale | $18.52 | 16,300 | $301.9K | 55,286 | |
BCAX | David Raben | Chief Medical Officer | Mar 4, 2026 | Option Exercise | $3.79 | 16,300 | $61.8K | 71,586 | |
BCAX | David Raben | Chief Medical Officer | Mar 3, 2026 | Sale | $18.45 | 200 | $3.7K | 55,286 | |
BCAX | David Raben | Chief Medical Officer | Mar 3, 2026 | Option Exercise | $3.79 | 200 | $758 | 55,486 | |
BCAX | Raben David | — | Mar 4, 2026 | Proposed Sale | $18.52 | 16,300 | $301.9K | — | |
BCAX | Raben David | — | Mar 3, 2026 | Proposed Sale | $18.45 | 200 | $3.7K | — | |
BCAX | Raben David | — | Nov 25, 2025 | Proposed Sale | $18.84 | 5,500 | $103.6K | — | |
BCAX | Raben David | — | Nov 24, 2025 | Proposed Sale | $18.45 | 5,500 | $101.5K | — | |
BCAX | Raben David | — | Oct 9, 2025 | Proposed Sale | $18.45 | 22,000 | $405.9K | — |